#United States #Detroit #pancreatic cancer #cancer awareness #Karmanos Institute

Recognizing November as Pancreatic Cancer Awareness Month

November is designated as Pancreatic Cancer Awareness Month, bringing crucial attention to one of the most lethal forms of cancer. This month, the Barbara Ann Karmanos Cancer Institute, along with numerous cancer centers across the nation, is spearheading initiatives to educate the public about pancreatic cancer and the pressing need for increased awareness.

Understanding Pancreatic Cancer

Pancreatic cancer begins in the pancreas, an organ vital for digestion and blood sugar regulation. The majority of these cancers, approximately 95%, are classified as pancreatic adenocarcinoma. According to the American Cancer Society, around 67,440 new cases are expected to be diagnosed in the United States in 2025, a stark reminder of the seriousness of this disease. Moreover, pancreatic cancer accounts for about 8% of all cancer deaths, with an estimated 51,980 fatalities in the same year.

Risk Factors and Symptoms

Pancreatic cancer is particularly insidious, as it often presents no symptoms in its early stages, making early detection extremely challenging. Common symptoms that may manifest later include:

• - Jaundice: Yellowing of the skin and eyes
• - Back or abdominal pain
• - Unexplained weight loss
• - Nausea and vomiting
• - Signs of diabetes: Such as excessive thirst, frequent urination, and unexpected hunger

Several lifestyle choices can increase the risk of developing pancreatic cancer. Smoking is a significant contributor, with studies suggesting that up to 25% of pancreatic cancer cases may be attributable to tobacco use. Obesity, chronic pancreatitis, and exposure to certain chemicals also elevate risk factors. Additionally, uncontrollable factors such as age, race, and family history play crucial roles.

Karmanos Cancer Institute's Commitment

The Karmanos Cancer Institute has assembled a specialized team dedicated to tackling pancreatic cancer. This multidisciplinary team comprises experts in surgery, medical and radiation oncology, radiology, pathology, nursing, nutrition, social work, and genetic counseling. Utilizing a collaborative approach, they produce tailored treatment plans aimed at achieving optimal patient outcomes.

Dr. Wasif Saif, a medical oncologist at Karmanos, emphasizes the institute’s commitment to advancing pancreatic cancer treatments. He notes, "Despite the challenges posed by this type of cancer, we are committed to providing patients with access to clinical trials featuring innovative therapies not yet available in standard practice."

Clinical Trials and Research

Karmanos is actively involved in clinical research to explore new therapeutic strategies. These trials not only contribute to medical knowledge but also optimize treatment options, ultimately extending patients’ time with loved ones. If you or a family member are facing pancreatic cancer, the Karmanos team encourages you to consider the clinical trials available through their facility.

Conclusion and Call to Action

The looming threat of pancreatic cancer underscores the importance of awareness and early detection. It is essential to understand personal risk factors and seek medical advice if symptoms arise. For more information about pancreatic cancer and available resources, visit karmanos.org or call 1-800-KARMANOS.

Together, let us raise awareness this November, leading the fight against pancreatic cancer and striving for a future where fewer lives are lost to this formidable disease.